A phase 1, placebo controlled study of the safety of 3% w/w SPL7013 gel, administered to the penis of healthy male volunteers once daily for seven days

Trial Profile

A phase 1, placebo controlled study of the safety of 3% w/w SPL7013 gel, administered to the penis of healthy male volunteers once daily for seven days

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Jun 2016

At a glance

  • Drugs Astodrimer (Primary)
  • Indications Bacterial vaginosis; Herpes simplex virus infections; HIV infections
  • Focus Adverse reactions
  • Sponsors Starpharma
  • Most Recent Events

    • 01 Apr 2009 Results published in the Journal of Acquired Immune Deficiency Syndromes.
    • 15 Jan 2008 Status changed from in progress to completed.
    • 22 Jul 2007 Results have been presented.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top